
Spyre Therapeutics: Q1 Earnings Snapshot
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $44.8 million in its first quarter. On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 74 cents. The results topped …